Table 2.

MIC values (µg/mL) of albomycin δ₂ (1b) against clinical isolates of S. pneumoniae and S. aureus

Strains	1b	Cipro.	Vanco.	Peni.	Strains	1b	Cipro.	Vanco.	Peni.
S. pneumoniae 30	0.0039	1	≤1	≥2	S. pneumoniae S13	2	0.5	≤1	≥2
S. pneumoniae 33	0.0039	1	0.5	≤0.0625	S. pneumoniae S15	8	0.5	0.25	≥2
S. pneumoniae 10	0.0078	0.5	0.5	≥2	S. pneumoniae 29	16	>4	≤1	≥2
S. pneumoniae 28	0.0078	1	≤1	1	S. aureus S13	0.0625	0.25	1	≥0.5
S. pneumoniae 31	0.0078	0.5	0.5	1	S. aureus S19	0.0625	0.25	1	≥0.5
S. pneumoniae 32	0.0078	1	0.5	≤0.0625	S. aureus S15	0.125	1	1	≥0.5
S. pneumoniae 42	0.0078	1	0.5	≥2	S. aureus S17	0.125	0.25	1	≥0.5
S. pneumoniae S14	0.0078	0.5	0.25	0.5	S. aureus S21	0.125	0.5	1	≥0.5
S. pneumoniae 26	0.0156	1	≤1	≥2	S. aureus S12 (MRSA)	0.25	0.5	1	≥0.5
S. pneumoniae 43	0.0156	1	0.5	≥2	S. aureus S14 (MRSA)	0.25	0.25	1	≥0.5
S. pneumoniae 44	0.0156	1	0.5	≤0.0625	S. aureus S16	0.25	>4	1	≥0.5
S. pneumoniae 09	0.0312	1	0.5	≥2	S. aureus S18 (MRSA)	0.25	0.5	2	≥0.5
S. pneumoniae 27	0.0625	0.5	≤1	≥2	S. aureus S22	0.25	0.5	1	≥0.5
S. pneumoniae 23	0.25	1	≤1	0.5

These clinical pathogens were freshly isolated from Children’s Hospital of Chongqing Medical University, Chongqing, China

Cipro. Ciprofloxacin, Vanco. Vancomycin, Peni. Penicillin G